Over the past 12 months, Marker Therapeutics insiders made no open-market purchases or sales of the stock.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Enterprise Associates 16, L.P. New | TenPercentOwner | 1,625,678 | 0 | 1,625,678 | 71.4% | 23 Dec, 2024 |
| 2 | Steve Elms | Director | 0 | 325,370 | 325,370 | 14.3% | 26 Dec, 2024 |
| 3 | Juan Vera | Chief Scientific Officer Coo | 267,185 | 0 | 267,185 | 11.7% | 28 Mar, 2022 |
| 4 | Peter L. Hoang | President And Ceo | 48,329 | 0 | 48,329 | 2.1% | 28 Mar, 2022 |
| 5 | Anthony H. Kim | Chief Financial Officer | 11,444 | 0 | 11,444 | 0.5% | 28 Mar, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 17 Nov, 2025 | Norman David Eansor | Director | Acquired A | 84,411 | $0.00 | $0 | 84,411 | Direct |
| 17 Nov, 2025 | Katharine Knobil | Director | Acquired A | 84,411 | $0.00 | $0 | 84,411 | Direct |
| 17 Nov, 2025 | Steve Elms | Director | Acquired A | 84,411 | $0.00 | $0 | 84,411 | Direct |
| 17 Nov, 2025 | Katharine Knobil | Director | Acquired A | 137,330 | $0.00 | $0 | 137,330 | Direct |
| 17 Nov, 2025 | Steve Elms | Director | Acquired A | 137,330 | $0.00 | $0 | 137,330 | Direct |
| 17 Nov, 2025 | Norman David Eansor | Director | Acquired A | 137,330 | $0.00 | $0 | 137,330 | Direct |
| 31 Oct, 2025 | Juan Vera | Chief Executive Officer | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 31 Oct, 2025 | Kathryn Penkus Corzo | Director | Acquired A | 147,611 | $0.00 | $0 | 147,611 | Direct |
| 12 Feb, 2025 | Juan Vera | President And Ceo | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 12 Feb, 2025 | Katharine Knobil | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 12 Feb, 2025 | Norman David Eansor | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 12 Feb, 2025 | Steve Elms | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 23 Dec, 2024 | Steve Elms | Director | Acquired P | 11,085 | $3.20 | $35.47K | 325,370 | Indirect |
| 23 Dec, 2024 | Enterprise Associates 16, L.P. New | TenPercentOwner | Acquired P | 554,250 | $3.20 | $1.77Mn | 1,625,678 | Direct |
| 06 Jun, 2023 | Steve Elms | Director | Acquired A | 8,000 | $0.00 | $0 | 8,000 | Direct |
| 06 Jun, 2023 | John Robert Wilson | Director | Acquired A | 8,000 | $0.00 | $0 | 8,000 | Direct |
| 06 Jun, 2023 | Katharine Knobil | Director | Acquired A | 8,000 | $0.00 | $0 | 8,000 | Direct |
| 10 May, 2023 | Juan Vera | President And Ceo | Acquired A | 100,000 | $0.00 | $0 | 100,000 | Direct |
| 27 Feb, 2023 | Juan Vera | Chief Scientific Officer Coo | Acquired A | 46,487 | $0.00 | $0 | 46,487 | Direct |
| 27 Feb, 2023 | Anna Szymanska | Vice President, Quality | Acquired A | 29,947 | $0.00 | $0 | 29,947 | Direct |